A -year-old woman with severe, seropositive rheumatoid arthritis is evaluated in the rheumatology clinic. Her disease has progressed despite optimized therapy with methotrexate. The physician decides to initiate a tumor necrosis factor (TNF) inhibitor. The patient expresses concern about the financial burden of this new therapy, as she recently switched to an employer-sponsored high-deductible health plan.
The clinic's financial counselor reviews her insurance benefits for the new calendar year:
* Annual deductible: USD
* Coinsurance: (patient responsibility after the deductible is met)
* Annual out-of-pocket maximum: USD
The patient has not utilized any healthcare services yet this year, meaning USD has been applied to her deductible and out-of-pocket maximum. The negotiated rate for a one-month supply of the TNF inhibitor is USD .
What is the exact out-of-pocket amount (in dollars) the patient will be required to pay for her first month's supply of this medication?
Answer: 2900 dollars